Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 481-490 of 1760 for

Edit search filters
  1. 64Cu-SAR-bisPSMA And 67Cu-SAR-bisPSMA For Identification And Treatment Of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

    Rochester, MN

  2. Fasting Mimicking Diet For Reducing Immune Related Adverse Events For Cancer Patients On Immune Checkpoint Inhibitors, FMD-ICI Trial

    Jacksonville, FL

  3. A Study Of AP160-Complex In Advanced Solid Tumors

    Rochester, MN

  4. Combination Treatment Therapy Approaches For The Treatment Of High-Risk Multiple Myeloma, REACH Trial

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Study Of CG0070 Given In Combination With Pembrolizumab, In Non Muscle Invasive Bladder Cancer, Unresponsive To Bacillus Calmette-Guerin

    Rochester, MN

  6. Short-course Radiation Therapy For Hepatocellular Carcinoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. First In Human Study Of TORL-1-23 In Participants With Advanced Cancer

    Rochester, MN

  8. A Study To Evaluate The Safety, Effectiveness And Tolerability Of APG-2575 In Patients With Waldenström Macroglobulinemia

    Jacksonville, FL

  9. A Study To Evaluate Combination Therapy To Treat Newly-diagnosed Diffuse Anaplastic Wilms Tumors And Relapsed Favorable Histology Wilms Tumors A Study Of Combination Chemotherapy For Patients With Newly Diagnosed DAWT And Relapsed FHWT

    Rochester, MN

  10. Belantamab, Lenalidomide, And Daratumumab For Newly-diagnosed Multiple Myeloma

    Rochester, MN

.

Mayo Clinic Footer